Interdialytic home systolic blood pressure variability increases all-cause mortality in hemodialysis patients
- PMID: 38549547
- PMCID: PMC10979187
- DOI: 10.1002/clc.24259
Interdialytic home systolic blood pressure variability increases all-cause mortality in hemodialysis patients
Abstract
Background: The association between Interdialytic home blood pressure variability (BPV) and the prognosis of patients undergoing maintenance hemodialysis (MHD) largely unknown.
Hypothesis: We proposed the hypothesis that interdialytic home BPV exert effect on cardiac and all-cause mortality among individuals undergoing MHD.
Methods: A total of 158 patients receiving MHD at the hemodialysis unit of Wuhan Fourth Hospital between December 2019 and August 2020 were included in this prospective cohort study. Patients were divided into tertiles according to the systolic BPV (SBPV), and the primary endpoints were cardiac and all-cause death. Kaplan-Meier analysis was used to assess the relationship between long-term survival and interdialytic home SBPV. In addition, Cox proportional hazards regression models were used to identify risk factors contributing to poor prognosis.
Results: The risk of cardiac death and all-cause death was gradually increased in patients according to tertiles of SBPV (3.5% vs. 14.8% vs. 19.2%, p for trend = .021; and 11.5% vs. 27.8% vs. 44.2%, p for trend <.001). The Cox regression analysis revealed that compared to Tertile 1, the hazard ratios for all-cause mortality in Tertile 2 and Tertile 3 were 3.13 (p = .026) and 3.24 (p = .021), respectively, after adjustment for a series of covariates.
Conclusions: The findings revealed a positive correlation between increased interdialytic home SBPV and elevated mortality risk in patients with MHD.
Keywords: blood pressure variability; hemodialysis; home blood pressure measurement; mortality.
© 2024 The Authors. Clinical Cardiology published by Wiley Periodicals LLC.
Conflict of interest statement
The authors declare no conflict of interest.
Figures



Comment in
-
Exploring the role of vascular frailty in understanding blood pressure variability and mortality risk among end-stage kidney disease patients undergoing hemodialysis.Clin Cardiol. 2024 May;47(5):e24281. doi: 10.1002/clc.24281. Clin Cardiol. 2024. PMID: 38738580 Free PMC article. No abstract available.
-
How to demonstrate the prognostic impact of interdialytic home blood pressure variability in dialytic patients.Clin Cardiol. 2024 May;47(5):e24279. doi: 10.1002/clc.24279. Clin Cardiol. 2024. PMID: 38775272 Free PMC article. No abstract available.
References
-
- Couser WG, Remuzzi G, Mendis S, Tonelli M. The contribution of chronic kidney disease to the global burden of major noncommunicable diseases. Kidney Int. 2011;80(12):1258‐1270. - PubMed
-
- O'Lone E, Viecelli AK, Craig JC, et al. Cardiovascular outcomes reported in hemodialysis trials. J Am Coll Cardiol. 2018;71(24):2802‐2810. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical